Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overview of the PROVE studies evaluating the use of telaprevir in chronic hepatitis C genotype 1 patients
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 9, Issue 2, Pages 151-160
Publisher
Informa UK Limited
Online
2010-12-14
DOI
10.1586/eri.10.153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Review article: specifically targeted anti-viral therapy for hepatitis C - a new era in therapy
- (2010) C. M. Lange et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection
- (2010) Ira M. Jacobson et al. Clinical Gastroenterology and Hepatology
- Telaprevir for Hepatitis C Re-treatment: An Open Door on a Long and Winding Road
- (2010) Alessio Aghemo et al. GASTROENTEROLOGY
- Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus
- (2010) Alexander J. Thompson et al. GASTROENTEROLOGY
- Epidemiology of hepatitis B in the United States
- (2010) W. Ray Kim HEPATOLOGY
- Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- STAT-C: a full revolution or just a step forward?
- (2010) Laura Milazzo et al. LANCET
- Excitement grows for potential revolution in hepatitis C virus treatment
- (2010) Alisa Opar NATURE REVIEWS DRUG DISCOVERY
- Telaprevir for Previously Treated Chronic HCV Infection
- (2010) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus
- (2009) Ivan Gentile et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Progress towards improving antiviral therapy for hepatitis C with hepatitis C virus polymerase inhibitors. Part I: Nucleoside analogues
- (2009) Nathaniel A Brown EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
- (2009) Thierry Poynard et al. GASTROENTEROLOGY
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Hepatitis C drug development at a crossroads
- (2009) David R. Nelson HEPATOLOGY
- Comment on the PROVE1 and PROVE2 clinical trials: “I was taking a picture of rapid virological response with telaprevir, but the background is unfocused!”
- (2009) Leonardo Baiocchi et al. HEPATOLOGY
- Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus-infected patients
- (2009) Simone Susser et al. HEPATOLOGY
- Baseline characteristics and early on-treatment response predict the outcomes of 2years of telbivudine treatment of chronic hepatitis B
- (2009) Stefan Zeuzem et al. JOURNAL OF HEPATOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- A Step Forward in Therapy for Hepatitis C
- (2009) Jay H. Hoofnagle NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection
- (2009) Christophe Hézode et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection
- (2009) John G. McHutchison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characterization of resistance mutations against HCV ketoamide protease inhibitors
- (2008) X TONG et al. ANTIVIRAL RESEARCH
- Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy
- (2008) David R. Nelson et al. Clinical Gastroenterology and Hepatology
- Emerging antiviral drugs
- (2008) Erik De Clercq EXPERT OPINION ON EMERGING DRUGS
- Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
- (2008) Thomas Kuntzen et al. HEPATOLOGY
- Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients
- (2008) Stefan Zeuzem JOURNAL OF HEPATOLOGY
- Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients
- (2008) Eric Lawitz et al. JOURNAL OF HEPATOLOGY
- Expert opinion on the treatment of patients with chronic hepatitis C
- (2008) S. Zeuzem et al. JOURNAL OF VIRAL HEPATITIS
- Molecular basis of telaprevir resistance due to V36 and T54 mutations in the NS3-4A protease of the hepatitis C virus
- (2008) Christoph Welsch et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More